rifampicin aki vasif
TRANSCRIPT
![Page 1: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/1.jpg)
Rare cause of AKIM.C. Vasif Mayan
For theDept of NEPHROLOGY
APMC 2015
GMKMCH SALEM
![Page 2: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/2.jpg)
HISTORY
• 28 year old female
• PRESENTING ILLNESS– Abdominal Pain 10 days– (Lumbar Pain)– Vomiting 10 days– Low grade fever– Myalgia
![Page 3: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/3.jpg)
• No h/o oliguria• No h/o rashes• No h/o jaundice• No h/o cola coloured urine• No h/o dysuria
• No h/o loose stools
• No history of DM/HTN/CKD/CLD/SLE
![Page 4: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/4.jpg)
HISTORY OF PAST ILLNESS
• Appendicectomy done 2yr back for recurrent abdominal pain. Biopsy revealed TB appendix
• Took Cat 1 ATT for 4 months
• Restarted on (intermittent) ATT for the past 10 days.
defaulted
![Page 5: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/5.jpg)
EXAMINATION
• Conscious • GC stable• Afebrile• Mild Pallor +• No Icterus/ Cyanosis/ Clubbing• No Generalised LNE• No Bilateral Pitting Pedal edema
![Page 6: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/6.jpg)
SYSTEM EXAMINATION• CVS S1, S2 + Normal
No murmurs
• RS BAE+, NVBSChest Clear
• ABDOMEN diffuse tenderness+bowel sounds +No organomegaly
• NS Consious,PEARLNo FND
![Page 7: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/7.jpg)
Provisional Diagnosis
• ? DRUG INDUCED GASTRITIS• ? TB ABDOMEN
![Page 8: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/8.jpg)
INVESTIGATIONS
• TC 9800• DC N77 L20 E3• Hb 10gm• ESR 30mm/1st Hour• PCV 30• RBC 3.2 million/mm3• RBS 52mg%
![Page 9: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/9.jpg)
RFT and LFT• SGOT91 IU/L• SGPT 27 IU/L• Bilirubin Total 0.7 mg%• Bilirubin Direct 0.4 mg%
• S. Urea 130mg/dl• S. Creatinine 3.8 mg/dl
• USG Abdomen– Rt kidney 11x5cm– Lt Kidney 12x5cm– Increased Echoes, CMD absent
![Page 10: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/10.jpg)
DAY S. Creatinine S. Urea S. Sodium S. Potassium
1 3.8 130 134 4.72 4.8 156 139 4.94 9.2 170 140 4.96 9.4 162 147 5.67 8.4 138 133 5.18 8.0 132 136 4.510 6.8 99 140 4.311 5.9 83 133 4.913 3.9 6914 2.4 66 137 4.617 1.0 34
![Page 11: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/11.jpg)
1 2 3 4 5 6 7 8 9 10 110
1
2
3
4
5
6
7
8
9
10
S. Creatinine
Axis Title
![Page 12: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/12.jpg)
![Page 13: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/13.jpg)
![Page 14: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/14.jpg)
![Page 15: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/15.jpg)
• ACUTE INTERSTITIAL NEPHRITIS• ACUTE TUBULAR NECROSIS• RIFAMPICIN INDUCED AKI
![Page 16: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/16.jpg)
DISCUSSION
![Page 17: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/17.jpg)
INTERSTITIAL NEPHRITIS
![Page 18: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/18.jpg)
ACUTE TUBULAR NECROSIS
![Page 19: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/19.jpg)
NEPHROTOXICITY
![Page 20: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/20.jpg)
Methicillin – prototype drugCausing Interstitial nephritis
![Page 21: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/21.jpg)
![Page 22: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/22.jpg)
![Page 23: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/23.jpg)
![Page 24: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/24.jpg)
![Page 25: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/25.jpg)
Renal disease – dose reduction
![Page 26: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/26.jpg)
RIFAMPICIN INDUCED AKI
• Usually occur following re-treatment with an intermittent rifampicin regimen
• Intermission interval 5 months to 11 years• AKI manifested within 1st 10-20 days of re-
treatment• Withholding rifampicin and Supportive care
+/- dialysis can reverse the condition
• WHY???
![Page 27: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/27.jpg)
![Page 28: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/28.jpg)
MECHANISM
• Rifampicin dependent antibodies• Antibody accumulate during antigen-free interval• More in intermittent regimen and defaulters• immune complexes get deposited in the blood
vessels or interstitium and cause glomerular endotheliosis leading to tubular injury
• I antigen expressed on tubular epithelium through which immune complexes lead to tubular cell destruction
![Page 29: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/29.jpg)
• Immune complex deposition in interstitium and blood vessels
• Predominant pattern = Acute tubular necrosis• Interstitial edema
![Page 30: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/30.jpg)
Other pathogenic mechanisms
• Glomerular injury Nephortic syndrome(1 case)• Light chain proteinuria
(9cases)• Papillary necrosis• Crescent formation
![Page 31: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/31.jpg)
CLINICAL FEATURES
• Abdominal pain, nausea, vomiting• Flu like illness
• Mild anemia 96%• Leukocytosis 63%• Thrombocytopenia 50%• IMMUNE HEMOLYSIS 25%• Sterile Leucocyturia 83%• Oliguria/Anuria 96%• Mild hepatic injury
![Page 32: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/32.jpg)
![Page 33: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/33.jpg)
Prognosis
• Usually self resolving with withdrawal of drug and symptomatic management
• ? Role of steroid
• Prognostic factors• Duration of anuria• Severity of immune complex deposition
![Page 34: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/34.jpg)
Acute interstitial nephritis
• Most common etiologies are:– a) those related to the use of medications: 85% – b) those related to infectious agents: 10%– c) those associated to systemic disease or
glomerular diseases: 1%– d) idiopathic disease: 4%
![Page 35: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/35.jpg)
Acute interstitial nephritis: drugs• Etiology: AB (penicillins and cephalosporins,
methicillin), diuretics, NSAID’s, chinese herbs, lithium• Pathogenesis:
T cell mediated allergic - immune reaction on drug or drug-self protein conjugate (hapten) later followed by accumulation of lymphocytes, plasmocytes and histiocytes
• Histology:– Early signs: oedema, lymphocytes focally– Later: eosinophils, lymphocytes, plasmocytes and
histiocytes with granuloma formation(with giant cells) in 30 %, especially after AB
– Tubulitis (distal tubules): with breaks of TBM, necrosis of tubular cells and atrophy and loss of tubules.
![Page 36: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/36.jpg)
Acute drug induced interstitial nephritis
Granuloma
Oedema and focal inflammation
EOS
![Page 37: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/37.jpg)
Granuloma
![Page 38: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/38.jpg)
Acute drug induced interstitial nephritis
• Normally glomeruli not affected.• One exception: use of NSAID’s: can combine
ARF with Nephrotic Syndrome (effect of cell- mediated lymphokine directed reaction) inducing Minimal Lesions (effacement of foot processes of podocytes)
![Page 39: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/39.jpg)
Acute interstitial nephritis
Acute Renal Failure and reduced glomerular filtration rate:
- depends on the severity of inflammation
- interstitial oedema causes elevated intratubular pressure
- intratubular obstruction through intra luminal cells
- tubular backleak- vasoconstriction- tubuloglomerular feedback
![Page 40: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/40.jpg)
Outcome of drug- induced interstitial nephritis
• Recovery?
– Drug withdrawal: 60-90% in 1 to 12 mths– Irreversible with analgesics, NSAIDs, longterm use
• Adverse prognostic features– Marked interstitial inflammation– Granuloma (50% irreversible)– Tubular atrophy– Fibrosis
![Page 41: Rifampicin aki vasif](https://reader035.vdocuments.pub/reader035/viewer/2022062412/588091821a28ab9d738b476f/html5/thumbnails/41.jpg)